CASTAGNA, LUCA

CASTAGNA, LUCA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry 2014 A.M. GianniS. SecondinoL. Castagna + Article (author) -
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 2021 Castagna L.Corradini P.Guidetti A.De Philippis C. + Article (author) -
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party 2019 Castagna, LucaCorradini, Paolo + Article (author) -
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party 2018 Castagna, LucaMartinez, CarmenCorradini, Paolo + Article (author) -
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide 2018 Mussetti, A.de Philippis, C.Carniti, C.Cieri, N.Pennisi, M.Ciceri, F.Mariotti, J.Castagna, L.Corradini, P. + Article (author) -
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 2021 Di Vito, ClaraTapparo, MartaMariotti, JacopoBramanti, StefaniaCalvi, MichelaCastagna, LucaMavilio, Domenico + Article (author) -
Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies 2021 Castagna L.Capizzuto R.Mariotti J.De Philippis C.Calvi M.Mavilio D. + Article (author) -
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis 2017 L. CastagnaA. MussettiF. MauraC. de PhilippisP. Corradini + Article (author) -
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 2020 Castagna L.Mariotti J.Rambaldi A.Corradini P. + Article (author) -
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy 2020 Mariotti J.Evangelista A.Busca A.Sperotto A.Marano L.Mavilio D.Castagna L. + Article (author) -
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide 2022 Mariotti, JacopoMavilio, DomenicoBramanti, StefaniaCastagna, Luca + Article (author) -
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation : an Italian Prospective Multicenter Survey 2017 C. CattaneoS. GuidiL. CastagnaP. CorradiniA. Rambaldi + Article (author) -
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas 2021 Castagna L.Onida F.Mariotti J.De Philippis C.Corradini P. + Article (author) -
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 2016 P. CorradiniL. Castagna + Article (author) -
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 2017 F. OnidaL. CastagnaA. MussettiR. GrecoP. CorradiniA. Rambaldi + Article (author) -
Outcome of Allogeneic Transplantation for Mature T-cell Lymphomas: Impact of Donor Source and Disease Characteristics 2022 Castagna, LucaCorradini, Paolo + Article (author) -
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT 2017 F. CiceriP. CorradiniL. Castagna + Article (author) -
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma : a registry study by the European society for blood and marrow transplantation 2016 L. CastagnaP. Corradini + Article (author) -
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 2019 Mariotti, JacopoTaurino, DanielaBramanti, StefaniaDe Philippis, ChiaraDi Vito, ClaraMavilio, DomenicoCarlo-Stella, CarmeloCastagna, Luca + Article (author) -
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC 2019 Castagna, LucaCorradini, Paolo + Article (author) -